SAWAI GROUP HOLDINGS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,113 JPY | +0.02% |
|
+4.93% | +17.35% |
Presenter SpeechKenzo Sawai (Executives)I would like to explain about the financial results of...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
6,112
JPY
Average target price
6,840
JPY
Spread / Average Target
+11.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.35% | 1.7B | |
| +40.73% | 739B | |
| +31.84% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.94% | 240B | |
| +9.47% | 210B | |
| -4.95% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 4887 Stock
- News Sawai Group Holdings Co., Ltd.
- Transcript : Sawai Pharmaceutical Co., Ltd., Q1 2019 Earnings Call, Aug 14, 2018
